UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Zoloft20mgpermlkoncentrat-SE-PLC-RA

Generated Narrative: RegulatedAuthorization Zoloft20mgpermlkoncentrat-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/15504

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100023206-00015504,http://ema.europa.eu/fhir/eurdId#2696; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Concentrate for oral solution; indication = Zoloft är indicerat för behandling av: Egentliga depressionsepisoder. Förebyggande av återkommande episoder med egentlig depression. Paniksyndrom med eller utan agorafobi. Tvångssyndrom (OCD) hos vuxna och barn/ungdomar i åldrarna 6-17 år. Social fobi. Posttraumatiskt stressyndrom (PTSD).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = sertraline

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1999-12-29

holder: Organization Upjohn EESV

Cases

-TypeDate[x]
*First Authorisation1999-12-29